Well, that's the thing; if the distribution had been PRed on OTC, then we should be very close to 100% certain that the ex dates are different.
However, as you have pointed out, it would be strange (dangerous in terms of potential lawsuits) if they didn't issue the distribution at all on OTC, but then again it doesn't make much sense to not issue a PR on OTC about the distribution in the first place either (and it does seem like Oslo Børs had to force the information out of them)
So, if people are feeling a bit risk-seeking, then have a look into the risk/reward. Extremely high reward ($1.26 - disregarding the second distribution and the increased value since 2016 - for <10 cents extra), but also somewhat high risk (25% premium)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.